Scared of Needles but Starting a Weight-Loss Shot?

This week a drug called retatrutide was all over the news, with The Guardian calling it the “Godzilla” of weight-loss drugs. In a large trial, adults living with obesity and type 2 diabetes lost close to a fifth of their body weight on the highest dose, and their blood sugar, blood pressure and cholesterol numbers moved in the right direction too. It is not approved anywhere yet. And like most drugs in its family, it is a once-a-week injection.

That last detail is the part the headlines skip. If you are scared of needles, a weekly shot is not a footnote, it is fifty-two appointments a year with the thing you least like. The good news: you are in very large company, the needles involved are smaller than most people picture, and there are practical ways to make the first few weeks feel more manageable.

What the retatrutide trial actually found

The trial, called TRIUMPH-2, was published in The Lancet on 29 September 2026. It enrolled 1,152 adults with type 2 diabetes and a BMI of 27 or higher, who injected one of three doses of retatrutide or a placebo once a week for 80 weeks.

According to Healio's summary of the paper, average weight loss was 11.9 percent on the 4 mg dose, 16.8 percent on 9 mg and 18.8 percent on 12 mg, against 5.1 percent on placebo. Those figures count everyone who started; looking only at people who stayed on treatment, the top dose reached 20.8 percent.

The "other important health benefits" in the headline refer to the rest of the results. Systolic blood pressure fell by 9.7 mm Hg on the highest dose versus 2.7 on placebo, and triglycerides, non-HDL cholesterol and a key marker of inflammation all dropped. The researchers also reported the familiar downside of this drug class: stomach side effects such as nausea and diarrhoea were common, mostly while doses were being stepped up.

None of this is advice to start, switch or stop anything. It is a trial result, the drug still needs regulators' approval, and whether any of these medicines suits a particular person is a conversation for their prescriber.

Why a weekly shot is a needle question too

Semaglutide (Wegovy, Ozempic), tirzepatide (Mounjaro, Zepbound) and now retatrutide have quietly turned injections into a weekly routine for adults who may not have thought about a needle since their school vaccinations. For a lot of people, that is the first time a needle has been a regular part of life rather than a once-a-year event.

Fear of needles is not rare. A 2019 meta-analysis by McLenon and Rogers estimated needle fear in 20 to 30 percent of young adults, and found that 16 percent of adult patients had skipped a flu vaccine because of it. If you have ever felt this way, our piece on being afraid of needles as an adult explains why it has nothing to do with toughness.

The picture gets sharper for people managing long-term conditions. A 2021 scoping review in PLOS ONE looked at needle fear in adults with chronic disease. In diabetes, studies using a dedicated questionnaire found fear of injecting in around 28 percent of adults, and in one study 31 percent of people named fear of needles as a barrier to starting insulin. The same review was candid about the gaps: approaches like distraction, relaxation and education are widely used, but the authors found only a small evidence base testing them properly.

How big are the needles on weight-loss pens?

Usually much smaller than the needle people imagine. Weight-loss pens use short, very fine needles designed to go just under the skin, not into a vein, which makes them a different experience from a blood draw.

Several pens go further and keep the needle out of sight altogether. Lilly's own guide to the Zepbound single-dose pen puts it simply: "There's no need to see or handle the needle of the pen." For people whose fear is mostly about the sight of the needle, that design detail matters more than any pep talk.

What tends to make the first few weeks easier

Nobody needs a lecture here, just a few things people commonly find useful.

Do the first one with someone. Many prescribers, pharmacies and clinics offer to walk people through the first injection, or to give it in person. It is a perfectly reasonable thing to ask for.

Rehearse before the day. The manufacturer's instruction videos are short. Watching them two or three times turns the unknown into a sequence of steps you have already seen.

Make it a ritual. Same day, same time, same chair. Predictability takes some of the edge off anticipation, which for many people is the worst part.

Give your attention somewhere else. Look away, breathe out slowly, put on a song you like or talk to someone. These are small ways to give the moment a different focus. Our seven ways to feel calmer before a shot go into more detail.

Tell your prescriber about the fear. It is useful information, not a confession. In the US there are now also once-daily pill options for weight management, the Wegovy pill approved in December 2025 and Lilly's Foundayo in 2026, and whether a pill or a pen fits better is exactly the kind of question to raise.

What this means for clinics running weekly injection visits

Some people prefer to have their weekly injection done in a clinic rather than at home, and weight-management practices, pharmacies and primary care teams are seeing a new rhythm: the same person, every week, for months.

That rhythm changes what a visit is worth. A nervous first appointment that goes badly is not one bad visit, it is a reason not to come back next week. We wrote about why the first two minutes decide whether a patient comes back, and repeat-injection clinics live that every seven days.

The details that make a weekly visit feel kinder are mostly simple: a quiet corner instead of a busy hallway, a nurse who explains before acting, and somewhere better for attention to go than the pen. That last one is what SendorVR is built for. A nurse starts a short, calming VR experience on a headset in a few seconds, and the visitor spends the moment somewhere else entirely, a gentler way to spend the part of the visit people tend to remember. It is a comfort amenity, not a treatment, and all care stays with the clinical team.

If your clinic runs weekly injection visits and you would like to see it from the chair, book a demo.

Frequently asked questions

Is retatrutide available yet?

No. As of late September 2026 it has not been approved by any regulator. It is still being studied in phase 3 trials.

How often are weight-loss injections given?

The best-known ones, semaglutide (Wegovy) and tirzepatide (Zepbound, Mounjaro), are injected once a week, and retatrutide was tested as a once-weekly injection too. Your prescriber's instructions are the ones that count.

Is there a weight-loss medication that does not use needles?

Yes. In the US, the Wegovy pill (oral semaglutide) was approved in December 2025 and Lilly's Foundayo (orforglipron) was approved in 2026, both taken once daily. Whether either is right for someone is a decision to make with their prescriber.

Is it normal to be scared of needles as an adult?

Very. Research puts needle fear at roughly 20 to 30 percent of young adults, and it is often more common among women than men. It says nothing about courage.

Can I have my weekly injection done at a clinic instead of at home?

Often, yes, depending on your prescriber and local services. If injecting yourself feels like a wall, it is worth asking whether a nurse or pharmacist can give the first doses with you.